As with the valsartan and losartan recalls in 2018 and 2019, the FDA has advised people on recalled quinapril to continue the medication until their doctor or pharmacist can
Macleods Pharmaceuticals Limited has initiated a voluntary recall in the United States, to the patient level, of 32 lots of Losartan Potassium USP Tablets (2 lots of 50mg East Windsor, New Jersey, Aurobindo Pharma USA, Inc
This recall was prompted due to Torrent USA TODAY
Doctors regularly prescribed antihypertensive drugs like Losartan, Valsartan, and Irbesartan to millions of patients in the United States and worldwide
The latest recall involves the following lot and batch number and the expiration dates on the packaging: Losartan potassium tablets 50 mg: BLl711A, BLl710A, November 2019 Vivimed Life Sciences Pvt Ltd (Vivimed) is recalling 19 lots of Losartan Potassium Tablets USP 25 mg, 50 mg, and 100 mg to consumer level
Drugmaker Pfizer issued a voluntarily recall of three prescription blood pressure medications — one name brand and two generics — due to the presence of elevated levels of a potentially cancer-causing impurity
Description: Losartan Potassium Tablets, USP 25 mg, Rx only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No
is voluntarily recalling four (4) lots of Quinapril Tablets to the patient (consumer/user) level due to the presence of a nitrosamine impurity, N-Nitroso-Quinapril This recall involves bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain lot numbers